| Today available in France for research purposes only. |
STEEN Solution™ ex-vivo assessment could expand the donor lung pool.
STEEN Solution™ is intended for assessment of isolated lungs after removal from the donor for eventual transplantation into a recipient.
About four of every five lungs offered for transplantation are currently rejected by present selection criteria. 1, 2 However, lungs from marginal and extended donors have been sucessfully used for transplantation for at least a decade and the concept is gradually gaining acceptance.3, 4, 5
The ex-vivo assessment of marginal lung function, including gaseous exchange, at 37 ºC was orginally developed for non heart beating donor lungs by Steen et al6, 7 and has since been adopted by other centers.8, 9.
Closed circuit perfusion of the lung mimics in-vivo conditions; the ventilated lung is perfused with a 15% deoxigenated suspension of red cells in STEEN Solution™ and the circuitry monitors critical parameters of gaseous exchange, pulmonary vascular resistance and other key variables under normothermic conditions. The STEEN Solution™ perfusate and circuitry can maintain stable lung function, without oedema formation, for at least two hours at 37 ºC.7, 8 |
The STEEN Soultion™ perfusate and machine perfusion methodology permit:
- A more refined functional ex-vivo evaluation of accept/reject criteria - Normothermic functional evaluation without oedema formation - Permits more rational allocation and use of donor lungs
|
Bibliography
1. Ware LB et at. Lancet 2002, 360:619-20. 2. Pierre A F et al. J thorac CardioVasc Surg. 2002,123;3:421-8. 3. Kron I et al. Ann Surg. 1993;217:518-24 4. Sundaresan S et al. J. thorac Cardiovasc Surg. 1995, 109:1075-80 5. Shumway S et al. Ann Thorac Surg. 1994, 57:92-5 6. Steen S et al. Lancet 2001,357:825-829 7. Steen S et al. Ann Thorac Surg 2003,76:244-52 8. Neyrinck A et al. J Heart Lung Transplant 2004,23;173 (abstr) 9. Wierup P et al. Ann Thorac Surg 2006,81:460-6
|
© ADDMEDICA - adding value for health Legal Information
|